News

Nota de prensa. Mesoblast

In a press release published in the Wall Street Journal, the biotechnology company Mesoblast Limited announced positive 12-month results for a clinical trial assessing allogeneic stem cell treatment of degenerative lumbar disc disease with a greater than 6-month history of moderate to severe chronic pain.

The clinical trial included 100 patients recruited from 13 hospitals in the USA and Australia who were randomly...

acuerdo Universidad de Zaragoza - ITRT

The University of Zaragoza has entered into a scientific collaboration agreement with ITRT of Centro Médico Teknon to support the conduct of new cell therapy projects, in partnership with LAGENBIO (Biochemical Genetics Laboratory), the cell therapy laboratory of the Faculty of Veterinary Medicine of the University of Zaragoza. The agreement establishes an action framework...

X Congreso INVESCOT

From 31 January to 1 February, Santiago de Compostela hosted the 10th Conference of the Spanish Society of Orthopaedics and Traumatology Research (INVESCOT). Dr Francesc Soler from ITRT's research team and EGARSAT presented a summary of the results from an ovine clinical trial, which assessed the regenerative potential of bone marrow mesenchymal stem cells...

células madre en artrosis. ITRT Teknon

Reference and link to the article recently published in "Osteoarthritis Cartilage". The article reports on a meta-analysis of 844 procedures conducted using autologous bone marrow mesenchymal stem cells selected and expanded in the laboratory and applied to the joints. The average follow-up was 21 months. The article concluded by confirming the safety of the cell product and the lack of adverse effects.

Peeters CM, Leijs MJ, Reijman M, van Osch GJ...

Red Tercel

The Meeting of the Instituto de Salud Carlos III Red TerCel Cell Therapy Network, which took place on 29 November 2014, played host to the "Committee of Good Clinical Practice in Cell Therapy",

chaired by Prof. Ramón Muñoz-Chápuli from the University of Málaga and attended by Dr Josep M. Canals (University of Barcelona), Dr Ruth Coll (XCELIA/BST of Barcelona), Dr Alberto Martínez Serrano (Autonomous University of Madrid), Dr Fermín Sánchez-Guijo (Salamanca...